Masakazu Nagashima
Overview
Explore the profile of Masakazu Nagashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katano T, Suda S, Ohta T, Miyagami M, Kodaira Y, Konaka C, et al.
J Nippon Med Sch
. 2025 Jan;
91(6):527-533.
PMID: 39756941
Background: Rehabilitation therapists are sometimes unaware of the possibility of undiagnosed atrial fibrillation (AF) and the importance of AF detection. Thus, we aimed to increase awareness among rehabilitation therapists of...
2.
Katano T, Suda S, Ohta T, Miyagami M, Kodaira Y, Konaka C, et al.
Front Neurol
. 2023 Sep;
14:1247020.
PMID: 37662047
Background: Cryptogenic stroke (CS) are heterogeneous in origin; however, most CS are embolic mechanism. Paroxysmal atrial fibrillation (AF) is suspected to be a major type of CS that leads to...
3.
Nagase Y, Nagashima M, Shimane K, Nishikawa T, Naito M, Tanaka S
Mod Rheumatol
. 2021 Dec;
32(3):517-521.
PMID: 34910195
Background: The present study aimed prospectively to investigate the effect of a combination of tumour necrosis factor inhibitors and bisphosphonates (TNFi with BP) on bone mineral density (BMD) and bone...
4.
Nagashima M, Takahashi H, Shimane K, Nagase Y, Wauke K
Arthritis Res Ther
. 2012 Oct;
14(5):R224.
PMID: 23079134
Introduction: To investigate the effects of bisphosphonates (Bis) (etidronate, alendronate, and risedronate), alone and in combination with statin, on the BMD (bone mineral density) and bone metabolism of rheumatoid arthritis...
5.
Murakami M, Shimane K, Takahashi H, Tomiyama J, Nagashima M
Mod Rheumatol
. 2012 Mar;
23(1):156-61.
PMID: 22391860
We here report a rare case of dual antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in a 38-year-old Japanese woman previously diagnosed with mixed connective tissue disease. The patient was found...
6.
Takenouchi K, Morishita M, Saitoh K, Wauke K, Takahashi H, Nagashima M
J Nippon Med Sch
. 2009 Nov;
76(5):240-6.
PMID: 19915307
We report herein the results of a retrospective study of 30 ankle arthrodesis procedures performed in 27 patients with rheumatoid arthritis from 1994 through 2001 using a novel design of...
7.
Ochi S, Taniguchi K, Nagashima M
Mod Rheumatol
. 2009 Jun;
19(4):443-6.
PMID: 19526307
Although rheumatoid arthritis (RA) and myositis are major autoimmune diseases, co-occurrence of the two is rare. We treated a patient who developed polymyositis (PM) following the treatment of RA with...
8.
Morishita M, Nagashima M, Wauke K, Takahashi H, Takenouchi K
J Rheumatol
. 2008 Feb;
35(3):407-13.
PMID: 18260178
Objective: To investigate the effects of vitamin K2 (Vit K2) alone or in combination with etidronate and risedronate on bone loss, osteoclast induction, and inflammation in patients with rheumatoid arthritis...
9.
Nagashima M, Kato K, Miyamoto Y, Takenouchi K
Clin Rheumatol
. 2007 Mar;
26(5):748-52.
PMID: 17332985
To preserve the function of metatarsophalangeal joints and to ensure forefoot stability in patients with rheumatoid arthritis (RA), we performed a modified Hohmann method for hallux valgus (HV) and telescoping...
10.
Shu G, Yamamoto K, Nagashima M
Mod Rheumatol
. 2006 Dec;
16(6):343-9.
PMID: 17164994
Patients with rheumatoid arthritis commonly suffer both systemic and periarticular osteoporosis. Bisphosphonates (BPs) are inhibitors of bone resorption, and several derivatives have been developed for treatment of enhanced bone resorption....